Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000730412 | SCV000858145 | uncertain significance | not provided | 2017-11-16 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002536445 | SCV003444146 | uncertain significance | Aspartylglucosaminuria | 2024-01-02 | criteria provided, single submitter | clinical testing | This sequence change falls in intron 7 of the AGA gene. It does not directly change the encoded amino acid sequence of the AGA protein. It affects a nucleotide within the consensus splice site. This variant is present in population databases (rs368144874, gnomAD 0.08%). This variant has not been reported in the literature in individuals affected with AGA-related conditions. ClinVar contains an entry for this variant (Variation ID: 594991). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003987682 | SCV004804371 | uncertain significance | not specified | 2024-01-11 | criteria provided, single submitter | clinical testing |